SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-016149
Filing Date
2018-11-14
Accepted
2018-11-14 16:43:32
Documents
69
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 514578
2 ex10-1.htm EX-10.1 112490
3 ex10-2.htm EX-10.2 166384
4 ex10-2_001.jpg GRAPHIC 103438
5 ex10-2_002.jpg GRAPHIC 162272
6 ex10-3.htm EX-10.3 447544
7 exhibita_001.jpg GRAPHIC 181714
8 ex31-1.htm EX-31.1 18918
9 ex31-2.htm EX-31.2 18983
10 ex32-1.htm EX-32.1 7419
11 ex32-2.htm EX-32.2 7575
  Complete submission text file 0001493152-18-016149.txt   5073670

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE heb-20180930.xml EX-101.INS 625279
13 XBRL SCHEMA FILE heb-20180930.xsd EX-101.SCH 59481
14 XBRL CALCULATION FILE heb-20180930_cal.xml EX-101.CAL 58233
15 XBRL DEFINITION FILE heb-20180930_def.xml EX-101.DEF 152045
16 XBRL LABEL FILE heb-20180930_lab.xml EX-101.LAB 384721
17 XBRL PRESENTATION FILE heb-20180930_pre.xml EX-101.PRE 245633
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 181184649
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1